Abstract
SummaryHuman thirty-eight-negative kinase-1 (TNK1) is implicated in cancer progression. The TNK1-UBA domain binds polyubiquitin and plays a regulatory role in TNK1 activity and stability. Sequence analysis suggests an unusual architecture for the TNK1 UBA domain, but an experimentally-validated molecular structure is undetermined. To gain insight into TNK1 regulation, we fused the UBA domain to the 1TEL crystallization chaperone and obtained crystals diffracting as far as 1.53 Å. A 1TEL search model enabled solution of the X-ray phases. GG and GSGG linkers allowed the UBA to reproducibly find a productive binding mode against its host 1TEL polymer and to crystallize at protein concentrations as low as 0.1 mg/mL. Our studies support a mechanism of TELSAM fusion crystallization and show that TELSAM fusion crystals require fewer crystal contacts than traditional protein crystals. Modeling and experimental validation suggest the UBA domain may be selective for both the length and linkages of polyubiquitin chains.
Publisher
Cold Spring Harbor Laboratory
Reference72 articles.
1. Tnk1: A Novel Intracellular Tyrosine Kinase Gene Isolated from Human Umbilical Cord Blood CD34+/Lin-/CD38-Stem/Progenitor Cells;Oncogene,1996
2. Gu, T.L. , Cherry, J. , Tucker, M. , Wu, J. , Reeves, C. and Polakiewicz, R.D. (2010). Identification of Activated Tnk1 Kinase in Hodgkin’s Lymphoma. Leukemia. Nature Publishing Group. https://doi.org/10.1038/leu.2009.293.
3. Ahmed, S. and Miller, W.T .(2022). The noncatalytic regions of the tyrosine kinase Tnk1 are important for activity and substrate specificity. JBC 298. https://doi.org/10.1016/j.jbc.2022.102664.
4. High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic;Cancer Cells Molecular cancer research,2011
5. RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5